Major depression, panic disorder, agoraphobia, social anxiety disorder, or generalized anxiety disorder
Conditions
Interventions
Compassion-Focused Therapy for the patient themselves and psychological education for significant others.
Sponsors
National Center of Neurology and Psychiatry
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Individuals who meet the criteria for major depressive disorder, panic disorder, agoraphobia, social anxiety disorder, or generalized anxiety disorder according to MINI. Individuals with moderate or higher levels of depressive symptoms (scoring 10 or above on the PHQ-9). Participants aged 18 to 65 at the time of screening. Individuals who have provided written consent for their significant others to participate in online psychological education. Individuals who have understood the purpose and content of this study and have provided written informed consent for their voluntary participation in the research.
Exclusion criteria
Exclusion criteria: Individuals who have been identified as having alcohol or substance dependence within 6 months from the time of screening. Individuals who have manic episodes, schizophrenia, or other psychotic disorders at the time of pre-intervention assessment, as assessed by MINI. (Note: These criteria, 5 and 6, will be assessed using the MINI.) Individuals who exhibit significant suicidal ideation at the time of pre-intervention assessment (those corresponding to MINI Module B, B10-14, 16). Significant others who have no history of mental illness in the past year. Individuals who have significant physical illnesses or severe cognitive impairments at the time of pre-intervention assessment, making the implementation of CFT difficult. Individuals who are aware, at the time of pre-intervention assessment, that attending more than 50% of the CFT sessions during the intervention period would be difficult. Individuals who are receiving other forms of psychotherapy or counseling at the time of pre-intervention assessment. Other individuals whom the principal investigator has deemed unsuitable as participants for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We will evaluate changes in depressive symptoms measured by the PHQ-9 at baseline, intake interview, pre-assessment, midterm assessment, and post-assessment using visual analysis and statistical analysis with Tau-U. | — |
Countries
Japan
Contacts
Public ContactKenichi Asano
National Center of Neurology and Psychiatry National Center for Cognitive Behavior Therapy and Research
Outcome results
None listed